FDA Adverse Event Injury Summary report: N

GYNECARE GYNEMESH* PS

MDR report key: 2881471 · Received December 20, 2012

Report

Report Number
2210968-2012-08300
Event Type
Injury
Date Received
December 20, 2012
Report Date
December 1, 2012
Manufacturer
ETHICON, INC.
Product Code
OTO
PMA / PMN Number
K013718
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MS, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE PATIENT UNDERWENT MESH IMPLANTATION IN ORDER TO TREAT RECURRENT PROLAPSE WITH ENTEROCELE AND CYSTOCELE, MALFUNCTIONING GU IMPLANT (ERODED PUBOVAGINAL SLING); AND VAGINAL SCARRING. IT WAS REPORTED THAT FOLLOWING INSERTION THE PATIENT EXPERIENCED PAIN, EROSION, EXTRUSION, INFECTION, URINARY/BOWEL PROBLEMS, RECURRENCE, BLEEDING, DYSPAREUNIA, NEUROMUSCULAR PROBLEMS AND VAGINAL SCARRING. IT WAS REPORTED THAT THE PATIENT UNDERWENT AN ADDITIONAL MESH IMPLANTATION ON (B)(6) 2011 IN ORDER TO TREAT CYSTOCELE WITH INCOMPETENT PUBOCERVICAL FASCIA AND HYPERMOBILE STRESS INCONTINENCE. (B)(4). IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA.

Additional Manufacturer Narrative · 1

(B)(4). CONCLUSION: NO CONCLUSION CAN BE DRAWN AT THIS TIME. SHOULD ADDITIONAL INFORMATION BE OBTAINED, A SUPPLEMENTAL 3500A FORM WILL BE SUBMITTED ACCORDINGLY. THIS IS ONE OF TWO MEDWATCHES BEING SUBMITTED. SEE ALSO MEDWATCH 2210968-2012-08299. THE SAME PATIENT IS REPRESENTED IN EACH MEDWATCH.

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT UNDERWENT A GYNECOLOGICAL PROCEDURE ON (B)(6) 2010 AND MESH WAS IMPLANTED. THE PATIENT EXPERIENCED PAIN, EROSION OF HER INTERNAL BODILY TISSUE AND OTHER INJURIES FOLLOWING THE PROCEDURE. THE PATIENT HAS UNDERGONE MULTIPLE SURGERIES AND REVISIONARY PROCEDURES. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GYNECARE GYNEMESH* PS MESH, SURGICAL, POLYMERIC OTO ETHICON, INC. NA BKP361

Patients

Seq Age Sex Outcome Treatment
1 35 YR Required Intervention